Printer Friendly

New arthritis drug.

The real breakthrough was when the COX-2 inhibiting nonsteroidal anti-inflammatory drugs (NSAIDs) first emerged. First was Celebrex. Next came Vioxx. Now there is Mobic (or meloxicam) for the treatment of the symptoms of osteoarthritis. For those who suffer chronic arthritis pain, these drugs were a true innovation. The first generation of NSAIDs worked by inhibiting both COX-1 and COX-2 enzymes because they could not distinguish between the two. COX-2 enzymes are involved in pain and swelling. COX-1 enzymes affect the prostaglandins that protect the stomach and kidneys. The new NSAIDs are smarter because they work only against the COX-2 enzymes--pain relief with fewer gastrointestinal side effects like bleeding. The new drug, Mobic, is expected to be less expensive than the very expensive Celebrex and Vioxx. For those who suffer chronic pain, having more options is good news.

(Food and Drug Administration, April, 2000)
COPYRIGHT 2001 American Running & Fitness Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Mobic
Publication:Running & FitNews
Article Type:Brief Article
Geographic Code:1USA
Date:Apr 1, 2001
Words:143
Previous Article:Prolotherapy? Could be a help.
Next Article:Getting ready for speed drills.
Topics:


Related Articles
Relieving ARTHRITIS PAIN Can Supplements Help?
Questions and Answers About Arthritis Pain.
GLUCOSAMINE & ARTHRITIS.
AMGEN GETS DRUG OK ARTHRITIS PRODUCT EXPANDS COMPANY'S MARKET REACH.
AMGEN FINISHES TRIALS FOR ARTHRITIS TREATMENT.
Questions and answers about arthritis pain.
The joint's a rockin: keeping arthritis at bay. .
Two arthritis drugs work best in tandem.
New Mealey's Report on Arthritis Drug Litigation.
"Arthritis Practitioner" from HMP Communications.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters